UK NSC recommends targeted prostate cancer screening for men with BRCA2 variants
The UK National Screening Committee has endorsed a risk-stratified approach to prostate cancer screening, focusing on men who carry a BRCA2 pathogenic variant and have a relevant family history of cancer.